Biotechnology
Manufacturing
Technology

Illumina

$303.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$5.08 (-1.65%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Illumina and other stocks, options, ETFs, and crypto commission-free!

About

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). Read More The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Employees
7,300
Headquarters
San Diego, California
Founded
1998
Market Cap
45.39B
Price-Earnings Ratio
54.57
Dividend Yield
0.00
Average Volume
967.19K
High Today
$308.68
Low Today
$301.62
Open Price
$308.15
Volume
294.02K
52 Week High
$372.61
52 Week Low
$225.82

Collections

Biotechnology
Manufacturing
Technology
Pharmaceutical
Health

News

TradingNewsNow21h

Current Valuation: Illumina (NASDAQ: ILMN)

Illumina trades as part of the healthcare sector and medical diagnostics and research industry. The company CEO is Francis A. DeSouza. Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products. Previous Intraday Trading Performance: The ILMN stock showed a previous change of -3.26% with an open at 319.08 and a close of 308.79. I...

88
The Motley FoolMar 21

Better Buy: Illumina vs. Guardant Health

Thanks to scientific breakthroughs, we're living in an age of miracles, according to David Gardner, cofounder of The Motley Fool.

986
Simply Wall StMar 20

What Investors Should Know About Illumina, Inc.’s (NASDAQ:ILMN) Financial Strength

Investors pursuing a solid, dependable stock investment can often be led to Illumina, Inc. (NASDAQ:ILMN), a large-cap worth US$46b. Big corporations are much sought after by risk-averse investors who find diversified revenue streams and strong capital returns attractive. However, its financial health remains the key to continued success. This article will examine Illumina’s financial liquidity and debt levels to get an idea of whether the company can deal with cyclical downturns and maintain funds to accomm...

158

Earnings

$0.69
$0.97
$1.24
$1.52
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 23, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.